CombiMatrix to Raise $6.8M in Private Placement to Keep Up With Rising Test Demand

This is the first time CombiMatrix has sought to raise funds since it restructured last year, when it shed its array tools and services business in order to focus exclusively on diagnostics.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.